Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
Psap
REST API REST API
Rattus norvegicus
Psap is differentially expressed in 78 experiments: 55 organism parts: frontal cortex, hippocampus, ... (53 more);, 8 disease states: normal, BDL 7 days, ... (6 more);, 14 cell types 2 cell lines 8 compound treatments and 20 other conditions.
Synonyms SGP-1, SGP1A
Orthologs psap (Danio rerio)   Psap (Mus musculus)   PSAP (Gallus gallus)   ENSCING00000006331 (Ciona intestinalis)   Sap-r (Drosophila melanogaster)   psap (Xenopus laevis)   (Compare orthologs)
Gene Ontology Term glycolipid transport, extracellular space, developmental growth, lysosome, Golgi apparatus, extracellular region, regulation of MAPKKK cascade, lipid metabolic process, sphingolipid metabolic process, mitochondrion, prostate gland growth, epithelial cell differentiation involved in prostate gland development
InterPro Term SapA, SaposinB, Saposin, Saposin-like, SapB_1, SapB_2, Saposin_chordata
UniProt Accession Q6P7A4, P10960
Search EB-eye ENSRNOG00000000571
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-15184, E-GEOD-19830, E-GEOD-20388, E-AFMX-7, E-GEOD-471, ... (17 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-20037

Factor Value U/D Experiments
Rat-1 fibroblast cell line TGR
1
E-GEOD-20037
Rat-1 fibroblast cell line 15.19
1
E-GEOD-20037


Cell type

studied in E-MEXP-31, E-GEOD-830, E-GEOD-2499, E-TABM-130, E-GEOD-2032 ... (5 experiments)

Factor Value U/D Experiments
Sertoli cell
1
2
E-MEXP-31, E-TABM-130
laminin binding germ cell
1
E-GEOD-830
neuron
1
E-GEOD-2499
1
E-TABM-130
spermatogonia
1
E-MEXP-31
total testis
1
E-MEXP-31
8 more value(s).


Disease state

studied in E-GEOD-1872, E-GEOD-594, E-GEOD-464, E-MEXP-2583

Factor Value U/D Experiments
Sham
1
E-MEXP-2583
moderate spinal cord injury
2
1
E-GEOD-464
severe spinal cord injury
1
E-GEOD-464
bone fracture
1
1
E-GEOD-594
breast carcinoma
1
E-GEOD-1872
BDL 7 days
1
E-MEXP-2583
2 more value(s).


Compound treatment

studied in E-GEOD-2303, E-MEXP-782, E-GEOD-6119, E-GEOD-22647

Factor Value U/D Experiments
control
9
1
E-GEOD-6119
valproic acid
1
E-GEOD-2303
AICAR
1
E-GEOD-22647
clofibrate
1
1
E-GEOD-2303
none
45
1
E-MEXP-782
pristane
1
E-MEXP-782
2 more value(s).


age (months)

studied in E-GEOD-21681

Factor Value U/D Experiments
28
1
E-GEOD-21681
18
1
E-GEOD-21681


behavioral performance
studied in E-GEOD-21681

Clinical treatment
studied in E-GEOD-7002, E-GEOD-738, E-GEOD-1685

Cohort
studied in E-GEOD-20388

compound_treatment_design
studied in E-TABM-12

Day
studied in E-GEOD-20659

Developmental stage
studied in E-GEOD-4236, E-GEOD-13793, E-GEOD-903, E-GEOD-20245

Fluidics machine
studied in E-TABM-536

Genetic modification
studied in E-GEOD-6428

Genotype
studied in E-GEOD-20037, E-GEOD-20214

Growth condition
studied in E-GEOD-7501, E-GEOD-1567, E-MEXP-532, E-GEOD-19653

Injury
studied in E-GEOD-2599

Material type
studied in E-GEOD-4192, E-GEOD-467, E-MEXP-2527

Phenotype
studied in E-MIMR-541

protocol
studied in E-GEOD-20895

Protocol type
studied in E-GEOD-691, E-MEXP-1565

Replicate
studied in E-GEOD-4192

Sampling time point
studied in E-MEXP-1565

Strain or line
studied in E-MEXP-776, E-TABM-197, E-TABM-457, E-GEOD-599, E-GEOD-2116, ... (6 experiments)

Treatment
studied in E-GEOD-16981, E-GEOD-19909

Processing time: 0.654 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM